Amy L. Walz, MD
Section Head, Oncology; Clinical Practice Director, Center for Cancer & Blood Disorders
Associate Professor of Pediatrics (Hematology, Oncology, and Stem Cell Transplantation), Northwestern University Feinberg School of Medicine
- Language:
- English
- Pronouns:
- She
- Her
- Accepting New Patients:
-
Yes
-
Offering Telemedicine Visits:
-
Yes
Location
Ann & Robert H. Lurie Children's Hospital of Chicago
225 E. Chicago Ave.Chicago, Illinois 60611
About
Dr. Walz received her medical degree from the University of Louisville School of Medicine in 2009, prior to completing her Pediatrics residency at the University of Texas Southwestern/Children's Medical Center Dallas. She then completed a fellowship in Pediatric Hematology/Oncology in 2015 and a fellowship in Developmental Therapeutics in 2016 at McGaw Medical Center of Northwestern University/Ann & Robert H. Lurie Children's Hospital of Chicago. She subsequently became a member of the Pediatric Hematology/Oncology division with a specialization in Solid Tumors at Ann & Robert H. Lurie Children's Hospital of Chicago in July 2016.
Her research interests involve the study of pediatric high-risk renal tumors and their underlying genetic drivers. As a member of the Children's Oncology Group's Renal Tumor Committee and the Pediatric Preclinical Testing Consortium Disease Committee, she participates in the development of new therapeutic clinical trials, including early phase clinical trials, for renal tumor patients. She serves as the Developmental Therapeutics co-lead for the Renal Tumor Committee and will be leading a Children's Oncology Group-wide clinical trial for the treatment of pediatric patients with newly diagnosed rhabdoid tumor.
In addition, she has also investigated circulating exosomes from pediatric solid tumor patients as biomarkers for use in diagnosis, monitoring of treatment response, and early detection of relapse. This work received funding through a National Institutes of Health R21 Grant in August 2019. Dr. Walz's clinical focus centers on the treatment of pediatric solid tumor patients, including those with renal tumors, liver tumors, germ cell tumors, and sarcomas.
Clinical Interests
Pediatric cancer, Pediatric solid tumors, Renal tumors, Wilms tumor, Malignant Rhabdoid tumor, Liver tumors, Hepatoblastoma, Sarcoma, Osteosarcoma, Ewing sarcoma, Rhabdomyosaroma, Non-Rhabdomyosarcoma Soft Tissue Sarcoma
Education & Training
Education: University of Louisville School of Medicine, Louisville, Kentucky, 2009; Eastern Kentucky University, Richmond, Kentucky, 2005
Postgraduate Training: Fellowship in developmental therapeutics, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, 2015-2016; Fellowship in pediatric hematology, oncology and stem cell transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, 2012-2015; Residency in pediatrics, Children's Medical Center Dallas, University of Texas Southwestern Medical Center, 2009-2012
Board Certifications: Pediatric Hematology-Oncology, Pediatrics
Professional Organizations: American Academy of Pediatrics, American Society of Pediatric Hematology Oncology, Children’s Oncology Group, Children’s Oncology Group – Central Pathology Reviewer (Renal Tumor Committee), International Society of Pediatric Oncology, International Society of Paediatric Oncology-Renal Tumor Study Group
